Hemispherx Biopharma Inc (NYSE American:HEB)

0.301
Delayed Data
As of Jun 15
 0.00 / 0.00%
Today’s Change
0.28
Today|||52-Week Range
0.74
-13.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues213.0K90.0K50.0K56.0K
 
 
 
 
 
Cost of Goods Sold94.5K133.0K79.0K92.5K
 
 
 
 
 
Depreciation And Amortization247.0K266.0K217.0K231.0K
 
 
 
 
 
 
Operating ExpensesGross Income-128.5K-309.0K-246.0K-267.5K
 
 
 
 
 
General Expenses2.6M2.3M2.5M2.3M
 
 
 
 
 
Research And Development1.1M787.0K814.0K855.0K
 
 
 
 
 
Total Operating Expenses2.9M2.7M2.8M2.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-2.7M-2.8M-2.6M
 
 
 
 
 
Extraordinary Credit529.0K1.4M56.0K--
 
 
 
 
Extraordinary Charge0.000.000.00-231.0K
 
 
Interest Expense On Debt19.0K51.0K69.0K139.0K
 
 
 
 
 
Other Expenses6.0K0.00785.0K223.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.2M-1.3M-2.0M-2.7M
 
 
 
 
 
Net Income-2.2M-1.3M-2.0M-2.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.3M30.1M32.9M36.3M
 
 
 
 
 
Shares To Calculate EPS Diluted27.3M30.1M32.9M36.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.04-$0.06-$0.07
 
 
 
 
 
EPS Diluted-$0.08-$0.04-$0.06-$0.08